Exabis Library
Welcome to the e-CCO Library!
P317: Patient satisfaction in a joint fistula clinic at a tertiary Inflammatory Bowel Disease centre in the United Kingdom
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P317: Postoperative complications, outcome, quality of life and self-image after ileal pouch-anal anastomosis in patients operated due to acute, severe or chronic, therapy refractory ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P317: Societal cost-of-illness of Inflammatory Bowel Disease has rapidly increased over the years and differs between continents: A systematic review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P317: Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P318 Artificial intelligence of the neural network-assistant for differential diagnosis of IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P318: Accuracy of magnetic resonance enterography for extraluminal complications of Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P318: Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P318: Does anti-tumour necrosis factor therapy decrease the risk of initial intestinal resection after the diagnosis of Crohn’s disease? A retrospective single-centre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P318: Intra-dermal with topical imiquimod pre-treatment versus intra-muscular hepatitis B vaccination in inflammatory bowel disease patients: a double-blind randomized controlled trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P318: Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P318: Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P318: Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P319: Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P319: Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P319: Combining anti-inflammatory treatment with antiviral treatment in severe cytomegalovirus-positive ulcerative colitis does not affect colectomy rate: a retrospective European multicentre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P319: Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P319: Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P319: Long-term outcomes after anti-TNF therapy withdrawal in patients with radiologically healed perianal Crohn’s fistulas
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P319: Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM